Get started
Author

Clemens Bittermann

Observed names: C Bitterman, C Bittermann, C. Bittermann, Clemens Bitterman
ORCID: 0000-0001-9048-5395
Observed ORCID: 0000-0001-9048-5395
OpenAlex ID: A5053125466
Dendritic Cell Vaccination in Medullary Thyroid Carcinoma
2004 · Anton Stift, Monika Sachet, et al. · Clinical Cancer Research · 64
Extracorporeal albumin dialysis in patients with Amanita phalloides poisoning
2003 · Peter Faybik, Hubert Hetz, et al. · Liver International · 53
Short‐term complications of wide‐lumen stapled anastomosis after ileocolic resection for Crohn’s disease: who is at risk?
2009 · S. Riss, C. Bittermann, et al. · Colorectal Disease · 39
Efficacy and safety of splenectomy in adult chronic immune thrombocytopenia
2003 · C. Zoghlami-Rintelen, A. Weltermann, et al. · Annals of Hematology · 31
Determinants for postoperative complications after laparoscopic intestinal resection for Crohn’s disease
2011 · Stefan Riss, Clemens Bittermann, et al. · Surgical Endoscopy · 26
Robot-assisted esophageal surgery using the da Vinci® Xi system: operative technique and initial experiences
2018 · A. Pötscher, C. Bittermann, et al. · Journal of Robotic Surgery · 21
Dual Immune Checkpoint Inhibition Plus Neoadjuvant Chemoradiotherapy in Rectal Cancer: A Randomized Clinical Trial
2025 · Johannes Laengle, Irene Kuehrer, et al. · JAMA Network Open · 16
PDF
Interim analysis of neoadjuvant chemoradiotherapy with sequential ipilimumab and nivolumab in rectal cancer (CHINOREC): A prospective randomized, open-label, multicenter, phase II clinical trial.
2022 · Johannes Laengle, Irene Kuehrer, et al. · Journal of Clinical Oncology · 6
Neoadjuvant chemoradiotherapy with sequential ipilimumab and nivolumab in rectal cancer (CHINOREC): A prospective randomized, open-label, multicenter, phase II clinical trial.
2021 · Johannes Laengle, Irene Kuehrer, et al. · Journal of Clinical Oncology · 4
Incidence and Immunopathology of Myositis in Rectal Cancer Patients Treated With Neoadjuvant Immune Checkpoint Inhibitors and Chemoradiotherapy: Findings From the CHINOREC Trial
2025 · Rebecca Zirnbauer, Simon Hametner, et al. · MedComm · 3
PDF
P08.04 Neoadjuvant chemoradiotherapy with sequential ipilimumab and nivolumab in rectal cancer (CHINOREC): a prospective randomized, open-label, multicenter, phase II clinical trial
2020 · J Laengle, I Kuehrer, et al. · Journal for ImmunoTherapy of Cancer · 3
PDF
Neoadjuvant chemoradiotherapy with ipilimumab and nivolumab in rectal cancer (CHINOREC): A prospective randomized, open-label, multicenter, phase II clinical trial.
2025 · Johannes Laengle, Irene Kuehrer, et al. · Journal of Clinical Oncology · 2
PDF
O-03.06 Neoadjuvant chemoradiotherapy with ipilimumab and nivolumab in rectal cancer (CHINOREC): A prospective randomized, open-label, multicenter, phase II clinical trial
2025 · M Bergmann, J Laengle, et al. · Journal for ImmunoTherapy of Cancer
PDF
Robot-assisted thoracoscopic surgery of primary and secondary intrathoracic goiter: Two case reports
2024 · Bianka Hummel, Vanja Podrascanin, et al. · European surgery. Supplement/European surgery
655 Pivotal screening and proposed treatment algorithm for immune checkpoint inhibitor–induced cardio/myotoxicities in neoadjuvant-treated rectal cancer patients: experience from the CHINOREC trial
2022 · Johannes Laengle, Jutta Bergler-Klein, et al. · Journal for ImmunoTherapy of Cancer
PDF
Robot-assisted laparoscopic rectal surgery: operative technique and initial experiences
2021 · Bianka Hummel, Anna Nagel, et al. · European surgery. Supplement/European surgery
Works count: 16
Citation count: 268
H-index: 7
I10-index: 7
Year
Topic
Type